Clinical, pharmacokinetic and technological aspects of the hydroxychloroquine sulfate

Journal Title: IOSR Journal of Pharmacy (IOSRPHR) - Year 2014, Vol 4, Issue 11

Abstract

 Developed originally as an antimalarial agent, hydroxychloroquine sulfate (HCQS) is often used as a slow-acting drug in treating disorders of connective tissue. Over the past two decades, several data have been accumulated on the systemic effects of HCQS, expanding the potential uses of this drug in different therapeutic classes. The purpose of this article was to conduct a narrative review with qualitative approach on clinical, pharmacokinetic and technological aspects of HCQS, aiming to gather relevant pieces of information for the development of new therapeutic approaches to this drug. A search of the literature of scientific experimental and theoretical studies in the period 1980-2013 was performed. According to the data collected, among the activities HCQS, there are the indications for the treatment of autoimmune diseases such as lupus erythematosus and rheumatoid arthritis. Reports also indicate that HCQS improves insulin sensitivity, ability to reduce thromboembolic events, reduction of lipid levels and treatment for infection by human immunodeficiency virus. The evidence found out ocular and cutaneous adverse effects and the formation of three chiral active metabolites, what encourages studies to evaluate the kinetic behavior of HCQS and the intrinsic physicochemical characteristics of the drug, which is yet poorly described in the literature

Authors and Affiliations

Leslie Raphael de Moura Ferraz , ; Fabiana Lícia Araújo dos Santos , Pablo de Ataíde Ferreira , Ricardo Tadeu Lourenço Maia Junior , Talita Atanazio Rosa , Larissa Araújo Rolim , Pedro José Rolim-Neto

Keywords

Related Articles

 Uveitis: Pathogenesis, Clinical presentations and Treatment

 Uveitis a vision threatening inflammation of uvea is prevalent worldwide. In the United States uveitis has prevalence of 2.3 million people and causes 10% of all cases of blindness. Uveitis is classified by the o...

 Seasonal dynamics of Fasciola hepatica burdens in sheep: A diagnostic study from Hazara Division, Pakistan

 The present survey was carried out in order to determine seasonal dynamics of Fasciola hpatica burdens in sheep at a diagnostic laboratory in Abbottabad, Pakistan using microscopic technique. In this study, 1...

 UPLCMS Method Development and Validation of Tablet Dosage form Containing Glimepiride, Metformin and Pioglitazone Using Internal Standard

 A simple, rapid, sensitive and specific Ultra performance liquid chromatography-tandem mass spectrometry method was developed and validated for simultaneous estimation and validation of tablet dosage form contain...

Evaluation of Aframomum melegueta aqueous seed extract on food and water consumption in albino rats

ABSTRACT:- This experiment was carried out to evaluate the effect of seed extract of Aframomum melegueta on water and feed intake in albino rats. The aqueous seed extract of Aframomum melegueta was administered (p.o) to...

Download PDF file
  • EP ID EP158278
  • DOI -
  • Views 87
  • Downloads 0

How To Cite

Leslie Raphael de Moura Ferraz, ; Fabiana Lícia Araújo dos Santos, Pablo de Ataíde Ferreira, Ricardo Tadeu Lourenço Maia Junior, Talita Atanazio Rosa, Larissa Araújo Rolim, Pedro José Rolim-Neto (2014).  Clinical, pharmacokinetic and technological aspects of the hydroxychloroquine sulfate. IOSR Journal of Pharmacy (IOSRPHR), 4(11), 53-64. https://europub.co.uk/articles/-A-158278